Related references
Note: Only part of the references are listed.Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection
Louise E. See Hoe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Blockade of PKCβ protects against remote organ injury induced by intestinal ischemia and reperfusion via a p66shc-mediated mitochondrial apoptotic pathway
Guangzhi Wang et al.
APOPTOSIS (2014)
Response to Letter Regarding Article, Ten-Eleven Translocation-2 (TET2) Is a Master Regulator of Smooth Muscle Cell Plasticity
Renjing Liu et al.
CIRCULATION (2014)
Propofol Ameliorates Hyperglycemia-Induced Cardiac Hypertrophy and Dysfunction via Heme Oxygenase-1/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Rats
Jinjin Xu et al.
CRITICAL CARE MEDICINE (2014)
Selective inhibition of protein kinase C β2 attenuates the adaptor P66Shc-mediated intestinal ischemia-reperfusion injury
Z. Chen et al.
CELL DEATH & DISEASE (2014)
Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats
Haobo Li et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Sevoflurane Preconditioning Attenuates Myocardial Ischemia/Reperfusion Injury via Caveolin-3-Dependent Cyclooxygenase-2 Inhibition
Jianli Zhao et al.
CIRCULATION (2013)
Hyperglycemia-Induced Protein Kinase C β2 Activation Induces Diastolic Cardiac Dysfunction in Diabetic Rats by Impairing Caveolin-3 Expression and Akt/eNOS Signaling
Shaoqing Lei et al.
DIABETES (2013)
N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes
Tingting Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfuntion in rats with streptozotocin-induced diabetes
Yanan Liu et al.
CLINICAL SCIENCE (2012)
Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes
Yaser Abdallah et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
N-Acetylcysteine and Allopurinol Synergistically Enhance Cardiac Adiponectin Content and Reduce Myocardial Reperfusion Injury in Diabetic Rats
Tingting Wang et al.
PLOS ONE (2011)
A PKC-beta inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic rats
Liping Wei et al.
APOPTOSIS (2010)
Apoptosis is not involved in the mechanism of myocardial dysfunction after resuscitation in a rat model of cardiac arrest and cardiopulmonary resuscitation
Fengqing Song et al.
CRITICAL CARE MEDICINE (2010)
PKCβ modulates ischemia-reperfusion injury in the heart
Linghua Kong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Reperfusion injury in acute myocardial infarction. From bench to cath tab. Part I: Basic considerations
Jean Pierre Monassier
ARCHIVES OF CARDIOVASCULAR DISEASES (2008)
Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury
Yousuke T. Horikawa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling
John W. Calvert et al.
DIABETES (2008)
A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-β inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy
Carolina M. Casellini et al.
DIABETES CARE (2007)
Activation of vascular protein kinase C-β inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance
K Naruse et al.
DIABETES (2006)
Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition
AJ Tompkins et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
The protein kinase C-β inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications
A Vinik
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Ruboxistaurin, a protein kinase C β inhibitor, as an emerging treatment for diabetes microvascular complications
SV Joy et al.
ANNALS OF PHARMACOTHERAPY (2005)
Myocyte apoptosis in heart failure
VPM van Empel et al.
CARDIOVASCULAR RESEARCH (2005)
Role of apoptosis in reperfusion injury
F Eefting et al.
CARDIOVASCULAR RESEARCH (2004)
Selective inhibition of protein kinase Cβ2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells
A Kouroedov et al.
CIRCULATION (2004)
Role of the mitochondrial permeability transition in myocardial disease
JN Weiss et al.
CIRCULATION RESEARCH (2003)
Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure
MGS Sutton et al.
CIRCULATION (2003)
Phosphorylation of glycogen synthase kinase-3β during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective
HY Tong et al.
CIRCULATION RESEARCH (2002)
Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction
M Ishihara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart
F Di Lisa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Left ventricular remodeling after myocardial infarction - Pathophysiology and therapy
MGS Sutton et al.
CIRCULATION (2000)
Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart
Y Fujio et al.
CIRCULATION (2000)
Share Paper
